MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.600
-0.070 (-2.62%)
Feb 21, 2025, 4:00 PM EST - Market closed

MEI Pharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019 - 2015
Net Income
-38.2217.78-31.84-54.45-41.31-47.17
Upgrade
Depreciation & Amortization
0.580.380.390.330.290.11
Upgrade
Loss (Gain) From Sale of Assets
-0.450.03----
Upgrade
Asset Writedown & Restructuring Costs
10.910.9---0.23
Upgrade
Stock-Based Compensation
0.832.283.598.3510.256.8
Upgrade
Other Operating Activities
1.92.430.33-19.84-18.1222.87
Upgrade
Change in Accounts Receivable
-0.099.96-2.46-4.72-2.35
Upgrade
Change in Accounts Payable
-0.96-3.15-1.781.563.92-2.35
Upgrade
Change in Unearned Revenue
--64.86-30.5816.22-4.4475.88
Upgrade
Change in Other Net Operating Assets
-10.61-16.35-2.541.5522.18-19.76
Upgrade
Operating Cash Flow
-36.04-50.47-52.48-48.75-31.9634.26
Upgrade
Capital Expenditures
--0.01-0.04-0.48-0.71-0.89
Upgrade
Investment in Securities
54.3149.1553.737.3725.42-105.4
Upgrade
Investing Cash Flow
54.8249.1453.696.8924.71-106.29
Upgrade
Issuance of Common Stock
---52.93.5378.51
Upgrade
Repurchase of Common Stock
---0.04-0.19--
Upgrade
Common Dividends Paid
--11.66----
Upgrade
Other Financing Activities
-0.21-0.21--3.65-0.06-3.73
Upgrade
Financing Cash Flow
-0.21-11.87-0.0449.053.4774.78
Upgrade
Net Cash Flow
18.57-13.21.177.2-3.792.74
Upgrade
Free Cash Flow
-36.04-50.48-52.52-49.23-32.6733.36
Upgrade
Free Cash Flow Margin
--77.31%-107.59%-120.95%-93.90%120.20%
Upgrade
Free Cash Flow Per Share
-5.41-7.58-7.88-7.87-5.717.33
Upgrade
Cash Income Tax Paid
----0.010
Upgrade
Levered Free Cash Flow
-13.0712.76-14.41-37.17-7.79-28.89
Upgrade
Unlevered Free Cash Flow
-13.0712.76-14.41-37.17-7.79-28.89
Upgrade
Change in Net Working Capital
-1.316.15-2.38-1.81-20.1518.85
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.